Abstract
Researchers have isolated a potent new immunosuppressive agent from bacteria growing in forest soil on Cheju Island, Korea. “Tautomycetin, which specifically induces apoptosis in activated T cells, is in late-phase preclinical trials and early phase I trials”, explains researcher Sang-Kyou Lee (Yonsei University, Korea). “Hopefully, it will be developed as an immunosuppressive agent for the treatment of graft rejection and autoimmune diseases in the near future.”
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
